Fayez Sarofim & Co’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $725M | Sell |
10,503,662
-708,837
| -6% | -$48.9M | 1.74% | 17 |
|
|
2025
Q1 | $779M | Sell |
11,212,499
-171,982
| -2% | -$11.9M | 1.94% | 16 |
|
|
2024
Q4 | $979M | Sell |
11,384,481
-832,637
| -7% | -$71.6M | 2.38% | 9 |
|
|
2024
Q3 | $1.45B | Sell |
12,217,118
-334,970
| -3% | -$39.9M | 3.7% | 4 |
|
|
2024
Q2 | $1.79B | Buy |
12,552,088
+736,251
| +6% | +$105M | 4.83% | 3 |
|
|
2024
Q1 | $1.52B | Buy |
11,815,837
+1,786
| +0% | +$229K | 4.52% | 3 |
|
|
2023
Q4 | $1.43B | Buy |
11,814,051
+210,087
| +2% | +$25.5M | 4.38% | 3 |
|
|
2023
Q3 | $1.06B | Buy |
11,603,964
+6,484,279
| +127% | +$590M | 3.56% | 6 |
|
|
2023
Q2 | $829M | Sell |
5,119,685
-160,672
| -3% | -$26M | 2.9% | 7 |
|
|
2023
Q1 | $840M | Buy |
5,280,357
+163,988
| +3% | +$26.1M | 2.94% | 8 |
|
|
2022
Q4 | $692M | Sell |
5,116,369
-101,735
| -2% | -$13.8M | 2.56% | 8 |
|
|
2022
Q3 | $520M | Buy |
5,218,104
+450,280
| +9% | +$44.9M | 2.05% | 13 |
|
|
2022
Q2 | $531M | Buy |
4,767,824
+661
| +0% | +$73.7K | 1.94% | 14 |
|
|
2022
Q1 | $529M | Sell |
4,767,163
-65,017
| -1% | -$7.22M | 1.67% | 19 |
|
|
2021
Q4 | $541M | Sell |
4,832,180
-90,094
| -2% | -$10.1M | 1.62% | 18 |
|
|
2021
Q3 | $473M | Sell |
4,922,274
-8,588
| -0.2% | -$825K | 1.56% | 20 |
|
|
2021
Q2 | $413M | Sell |
4,930,862
-34,493
| -0.7% | -$2.89M | 1.39% | 23 |
|
|
2021
Q1 | $335M | Sell |
4,965,355
-18,092
| -0.4% | -$1.22M | 1.23% | 30 |
|
|
2020
Q4 | $348M | Sell |
4,983,447
-16,730
| -0.3% | -$1.17M | 1.34% | 27 |
|
|
2020
Q3 | $347M | Sell |
5,000,177
-62,870
| -1% | -$4.37M | 1.49% | 24 |
|
|
2020
Q2 | $332M | Buy |
5,063,047
+838,111
| +20% | +$54.9M | 1.53% | 22 |
|
|
2020
Q1 | $254M | Sell |
4,224,936
-179,664
| -4% | -$10.8M | 1.56% | 24 |
|
|
2019
Q4 | $255M | Sell |
4,404,600
-115,224
| -3% | -$6.67M | 1.23% | 32 |
|
|
2019
Q3 | $234M | Buy |
4,519,824
+34,846
| +0.8% | +$1.8M | 1.2% | 31 |
|
|
2019
Q2 | $229M | Buy |
4,484,978
+13,726
| +0.3% | +$701K | 1.18% | 32 |
|
|
2019
Q1 | $234M | Buy |
4,471,252
+10,942
| +0.2% | +$572K | 1.23% | 29 |
|
|
2018
Q4 | $205M | Buy |
4,460,310
+1,965
| +0% | +$90.5K | 1.24% | 28 |
|
|
2018
Q3 | $210M | Sell |
4,458,345
-38,615
| -0.9% | -$1.82M | 1.1% | 31 |
|
|
2018
Q2 | $207M | Sell |
4,496,960
-144,498
| -3% | -$6.66M | 1.12% | 30 |
|
|
2018
Q1 | $229M | Sell |
4,641,458
-94,944
| -2% | -$4.68M | 1.24% | 28 |
|
|
2017
Q4 | $254M | Sell |
4,736,402
-297,677
| -6% | -$16M | 1.32% | 26 |
|
|
2017
Q3 | $242M | Sell |
5,034,079
-77,312
| -2% | -$3.72M | 1.27% | 26 |
|
|
2017
Q2 | $219M | Sell |
5,111,391
-173,561
| -3% | -$7.44M | 1.17% | 26 |
|
|
2017
Q1 | $181M | Sell |
5,284,952
-296,344
| -5% | -$10.2M | 0.99% | 32 |
|
|
2016
Q4 | $200M | Sell |
5,581,296
-296,362
| -5% | -$10.6M | 1.1% | 28 |
|
|
2016
Q3 | $244M | Sell |
5,877,658
-190,386
| -3% | -$7.91M | 1.33% | 23 |
|
|
2016
Q2 | $327M | Buy |
6,068,044
+126,829
| +2% | +$6.83M | 1.79% | 12 |
|
|
2016
Q1 | $322M | Sell |
5,941,215
-95,279
| -2% | -$5.17M | 1.85% | 11 |
|
|
2015
Q4 | $350M | Sell |
6,036,494
-238,814
| -4% | -$13.9M | 2.02% | 10 |
|
|
2015
Q3 | $341M | Sell |
6,275,308
-153,242
| -2% | -$8.32M | 1.97% | 11 |
|
|
2015
Q2 | $353M | Sell |
6,428,550
-271,604
| -4% | -$14.9M | 1.79% | 13 |
|
|
2015
Q1 | $359M | Buy |
6,700,154
+43,783
| +0.7% | +$2.34M | 1.76% | 12 |
|
|
2014
Q4 | $282M | Sell |
6,656,371
-100,713
| -1% | -$4.26M | 1.34% | 19 |
|
|
2014
Q3 | $322M | Sell |
6,757,084
-13,456
| -0.2% | -$641K | 1.5% | 17 |
|
|
2014
Q2 | $313M | Sell |
6,770,540
-243,971
| -3% | -$11.3M | 1.43% | 22 |
|
|
2014
Q1 | $320M | Buy |
7,014,511
+5,567,066
| +385% | +$254M | 1.52% | 18 |
|
|
2013
Q4 | $267M | Buy |
+1,447,445
| New | +$267M | 1.24% | 25 |
|
|
2013
Q2 | $232M | Buy |
+1,498,915
| New | +$232M | 1.17% | 28 |
|